Global Human Gene Therapy Market Research Report 2024(Status and Outlook)

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,000	153 Pages	Bosson Research	January, 2024	BOSS18517679

Best Price Guarantee
Price	from $3,000
Length	153 Pages
Publisher	Bosson Research
Published Date	January, 2024
SKU	BOSS18517679

Global Human Gene Therapy Market Research Report 2024(Status and Outlook)

Report Overview:

Gene therapy isa medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.

The Global Human Gene Therapy Market Size was estimated at USD 5383.35 million in 2023 and is projected to reach USD 7766.98 million by 2029, exhibiting a CAGR of 6.30% during the forecast period.

This report provides a deep insight into the global Human Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Gene Therapy market in any manner.

Global Human Gene Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biogen

Sarepta Therapeutics

Gilead Sciences

Amgen

Novartis

Orchard Therapeutics

Spark Therapeutics

Agc Biologics

Anges

Bluebird Bio

Jazz Pharmaceuticals

Dynavax Technologies

Human Stem Cells Institute

Sibiono Genetech

Shanghai Sunway Biotech

Uniqure N.V.

Gensight Biologics S.A.

Celgene Corporation

Cellectis

Sangamo Therapeutics

Mustang Bio

AGTC

Poseida Therapeutics

Market Segmentation (by Type)

Non-viral Vectors

Viral Vectors

Market Segmentation (by Application)

Neurological Diseases

Cancer

DMD (Duchenne Muscular Dystrophy)

Hepatological Diseases

Others

Geographic Segmentation

North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

•

1 Research Methodology and Statistical Scope: 1.1 Market Definition and Statistical Scope of Human Gene Therapy; 1.2 Key Market Segments; 1.2.1 Human Gene Therapy Segment by Type; 1.2.2 Human Gene Therapy Segment by Application; 1.3 Methodology & Sources of Information; 1.3.1 Research Methodology; 1.3.2 Research Process; 1.3.3 Market Breakdown and Data Triangulation; 1.3.4 Base Year; 1.3.5 Report Assumptions & Caveats
2 Human Gene Therapy Market Overview: 2.1 Global Market Overview; 2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030); 2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2019-2030); 2.2 Market Segment Executive Summary; 2.3 Global Market Size by Region
3 Human Gene Therapy Market Competitive Landscape: 3.1 Global Human Gene Therapy Sales by Manufacturers (2019-2024); 3.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2019-2024); 3.3 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3); 3.4 Global Human Gene Therapy Average Price by Manufacturers (2019-2024); 3.5 Manufacturers Human Gene Therapy Sales Sites, Area Served, Product Type; 3.6 Human Gene Therapy Market Competitive Situation and Trends; 3.6.1 Human Gene Therapy Market Concentration Rate; 3.6.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue; 3.6.3 Mergers & Acquisitions, Expansion
4 Human Gene Therapy Industry Chain Analysis: 4.1 Human Gene Therapy Industry Chain Analysis; 4.2 Market Overview of Key Raw Materials; 4.3 Midstream Market Analysis; 4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Gene Therapy Market: 5.1 Key Development Trends; 5.2 Driving Factors; 5.3 Market Challenges; 5.4 Market Restraints; 5.5 Industry News; 5.5.1 New Product Developments; 5.5.2 Mergers & Acquisitions; 5.5.3 Expansions; 5.5.4 Collaboration/Supply Contracts; 5.6 Industry Policies
6 Human Gene Therapy Market Segmentation by Type: 6.1 Evaluation Matrix of Segment Market Development Potential (Type); 6.2 Global Human Gene Therapy Sales Market Share by Type (2019-2024); 6.3 Global Human Gene Therapy Market Size Market Share by Type (2019-2024); 6.4 Global Human Gene Therapy Price by Type (2019-2024)
7 Human Gene Therapy Market Segmentation by Application: 7.1 Evaluation Matrix of Segment Market Development Potential (Application); 7.2 Global Human Gene Therapy Market Sales by Application (2019-2024); 7.3 Global Human Gene Therapy Market Size (M USD) by Application (2019-2024); 7.4 Global Human Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Human Gene Therapy Market Segmentation by Region: 8.1 Global Human Gene Therapy Sales by Region; 8.1.1 Global Human Gene Therapy Sales by Region; 8.1.2 Global Human Gene Therapy Sales Market Share by Region; 8.2 North America; 8.2.1 North America Human Gene Therapy Sales by Country; 8.2.2 U.S.; 8.2.3 Canada; 8.2.4 Mexico; 8.3 Europe; 8.3.1 Europe Human Gene Therapy Sales by Country; 8.3.2 Germany; 8.3.3 France; 8.3.4 U.K.; 8.3.5 Italy; 8.3.6 Russia; 8.4 Asia Pacific; 8.4.1 Asia Pacific Human Gene Therapy Sales by Region; 8.4.2 China; 8.4.3 Japan; 8.4.4 South Korea; 8.4.5 India; 8.4.6 Southeast Asia; 8.5 South America; 8.5.1 South America Human Gene Therapy Sales by Country; 8.5.2 Brazil; 8.5.3 Argentina; 8.5.4 Columbia; 8.6 Middle East and Africa; 8.6.1 Middle East and Africa Human Gene Therapy Sales by Region; 8.6.2 Saudi Arabia; 8.6.3 UAE; 8.6.4 Egypt; 8.6.5 Nigeria; 8.6.6 South Africa
9 Key Companies Profile: 9.1 Biogen; 9.1.1 Biogen Human Gene Therapy Basic Information; 9.1.2 Biogen Human Gene Therapy Product Overview; 9.1.3 Biogen Human Gene Therapy Product Market Performance; 9.1.4 Biogen Business Overview; 9.1.5 Biogen Human Gene Therapy SWOT Analysis; 9.1.6 Biogen Recent Developments; 9.2 Sarepta Therapeutics; 9.2.1 Sarepta Therapeutics Human Gene Therapy Basic Information; 9.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview; 9.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance; 9.2.4 Sarepta Therapeutics Business Overview; 9.2.5 Sarepta Therapeutics Human Gene Therapy SWOT Analysis; 9.2.6 Sarepta Therapeutics Recent Developments; 9.3 Gilead Sciences; 9.3.1 Gilead Sciences Human Gene Therapy Basic Information; 9.3.2 Gilead Sciences Human Gene Therapy Product Overview; 9.3.3 Gilead Sciences Human Gene Therapy Product Market Performance; 9.3.4 Gilead Sciences Human Gene Therapy SWOT Analysis; 9.3.5 Gilead Sciences Business Overview; 9.3.6 Gilead Sciences Recent Developments; 9.4 Amgen; 9.4.1 Amgen Human Gene Therapy Basic Information; 9.4.2 Amgen Human Gene Therapy Product Overview; 9.4.3 Amgen Human Gene Therapy Product Market Performance; 9.4.4 Amgen Business Overview; 9.4.5 Amgen Recent Developments; 9.5 Novartis; 9.5.1 Novartis Human Gene Therapy Basic Information; 9.5.2 Novartis Human Gene Therapy Product Overview; 9.5.3 Novartis Human Gene Therapy Product Market Performance; 9.5.4 Novartis Business Overview; 9.5.5 Novartis Recent Developments; 9.6 Orchard Therapeutics; 9.6.1 Orchard Therapeutics Human Gene Therapy Basic Information; 9.6.2 Orchard Therapeutics Human Gene Therapy Product Overview; 9.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance; 9.6.4 Orchard Therapeutics Business Overview; 9.6.5 Orchard Therapeutics Recent Developments; 9.7 Spark Therapeutics; 9.7.1 Spark Therapeutics Human Gene Therapy Basic Information; 9.7.2 Spark Therapeutics Human Gene Therapy Product Overview; 9.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance; 9.7.4 Spark Therapeutics Business Overview; 9.7.5 Spark Therapeutics Recent Developments; 9.8 Agc Biologics; 9.8.1 Agc Biologics Human Gene Therapy Basic Information; 9.8.2 Agc Biologics Human Gene Therapy Product Overview; 9.8.3 Agc Biologics Human Gene Therapy Product Market Performance; 9.8.4 Agc Biologics Business Overview; 9.8.5 Agc Biologics Recent Developments; 9.9 Anges; 9.9.1 Anges Human Gene Therapy Basic Information; 9.9.2 Anges Human Gene Therapy Product Overview; 9.9.3 Anges Human Gene Therapy Product Market Performance; 9.9.4 Anges Business Overview; 9.9.5 Anges Recent Developments; 9.10 Bluebird Bio; 9.10.1 Bluebird Bio Human Gene Therapy Basic Information; 9.10.2 Bluebird Bio Human Gene Therapy Product Overview; 9.10.3 Bluebird Bio Human Gene Therapy Product Market Performance; 9.10.4 Bluebird Bio Business Overview; 9.10.5 Bluebird Bio Recent Developments; 9.11 Jazz Pharmaceuticals; 9.11.1 Jazz Pharmaceuticals Human Gene Therapy Basic Information; 9.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview; 9.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance; 9.11.4 Jazz Pharmaceuticals Business Overview; 9.11.5 Jazz Pharmaceuticals Recent Developments; 9.12 Dynavax Technologies; 9.12.1 Dynavax Technologies Human Gene Therapy Basic Information; 9.12.2 Dynavax Technologies Human Gene Therapy Product Overview; 9.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance; 9.12.4 Dynavax Technologies Business Overview; 9.12.5 Dynavax Technologies Recent Developments; 9.13 Human Stem Cells Institute; 9.13.1 Human Stem Cells Institute Human Gene Therapy Basic Information; 9.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview; 9.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance; 9.13.4 Human Stem Cells Institute Business Overview; 9.13.5 Human Stem Cells Institute Recent Developments; 9.14 Sibiono Genetech; 9.14.1 Sibiono Genetech Human Gene Therapy Basic Information; 9.14.2 Sibiono Genetech Human Gene Therapy Product Overview; 9.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance; 9.14.4 Sibiono Genetech Business Overview; 9.14.5 Sibiono Genetech Recent Developments; 9.15 Shanghai Sunway Biotech; 9.15.1 Shanghai Sunway Biotech Human Gene Therapy Basic Information; 9.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview; 9.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance; 9.15.4 Shanghai Sunway Biotech Business Overview; 9.15.5 Shanghai Sunway Biotech Recent Developments; 9.16 Uniqure N.V.; 9.16.1 Uniqure N.V. Human Gene Therapy Basic Information; 9.16.2 Uniqure N.V. Human Gene Therapy Product Overview; 9.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance; 9.16.4 Uniqure N.V. Business Overview; 9.16.5 Uniqure N.V. Recent Developments; 9.17 Gensight Biologics S.A.; 9.17.1 Gensight Biologics S.A. Human Gene Therapy Basic Information; 9.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview; 9.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance; 9.17.4 Gensight Biologics S.A. Business Overview; 9.17.5 Gensight Biologics S.A. Recent Developments; 9.18 Celgene Corporation; 9.18.1 Celgene Corporation Human Gene Therapy Basic Information; 9.18.2 Celgene Corporation Human Gene Therapy Product Overview; 9.18.3 Celgene Corporation Human Gene Therapy Product Market Performance; 9.18.4 Celgene Corporation Business Overview; 9.18.5 Celgene Corporation Recent Developments; 9.19 Cellectis; 9.19.1 Cellectis Human Gene Therapy Basic Information; 9.19.2 Cellectis Human Gene Therapy Product Overview; 9.19.3 Cellectis Human Gene Therapy Product Market Performance; 9.19.4 Cellectis Business Overview; 9.19.5 Cellectis Recent Developments; 9.20 Sangamo Therapeutics; 9.20.1 Sangamo Therapeutics Human Gene Therapy Basic Information; 9.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview; 9.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance; 9.20.4 Sangamo Therapeutics Business Overview; 9.20.5 Sangamo Therapeutics Recent Developments; 9.21 Mustang Bio; 9.21.1 Mustang Bio Human Gene Therapy Basic Information; 9.21.2 Mustang Bio Human Gene Therapy Product Overview; 9.21.3 Mustang Bio Human Gene Therapy Product Market Performance; 9.21.4 Mustang Bio Business Overview; 9.21.5 Mustang Bio Recent Developments; 9.22 AGTC; 9.22.1 AGTC Human Gene Therapy Basic Information; 9.22.2 AGTC Human Gene Therapy Product Overview; 9.22.3 AGTC Human Gene Therapy Product Market Performance; 9.22.4 AGTC Business Overview; 9.22.5 AGTC Recent Developments; 9.23 Poseida Therapeutics; 9.23.1 Poseida Therapeutics Human Gene Therapy Basic Information; 9.23.2 Poseida Therapeutics Human Gene Therapy Product Overview; 9.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance; 9.23.4 Poseida Therapeutics Business Overview; 9.23.5 Poseida Therapeutics Recent Developments
10 Human Gene Therapy Market Forecast by Region: 10.1 Global Human Gene Therapy Market Size Forecast; 10.2 Global Human Gene Therapy Market Forecast by Region; 10.2.1 North America Market Size Forecast by Country; 10.2.2 Europe Human Gene Therapy Market Size Forecast by Country; 10.2.3 Asia Pacific Human Gene Therapy Market Size Forecast by Region; 10.2.4 South America Human Gene Therapy Market Size Forecast by Country; 10.2.5 Middle East and Africa Forecasted Consumption of Human Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030): 11.1 Global Human Gene Therapy Market Forecast by Type (2025-2030); 11.1.1 Global Forecasted Sales of Human Gene Therapy by Type (2025-2030); 11.1.2 Global Human Gene Therapy Market Size Forecast by Type (2025-2030); 11.1.3 Global Forecasted Price of Human Gene Therapy by Type (2025-2030); 11.2 Global Human Gene Therapy Market Forecast by Application (2025-2030); 11.2.1 Global Human Gene Therapy Sales (Kilotons) Forecast by Application; 11.2.2 Global Human Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings